PDF herunterladen
Aktuelle Neurologie 2004; 31(2): 79-85
DOI: 10.1055/s-2003-814850
Übersicht
© Georg Thieme Verlag Stuttgart · New York

Perioperative Risiken und Therapie bei Epilepsiepatienten

Perioperative Management in Epilepsy PatientsA.  Schulze-Bonhage1 , B.  Feil1 , B.  Zieger2
  • 1Neurozentrum, Universitätsklinikum Freiburg
  • 2Zentrum für Kinderheilkunde und Jugendmedizin, Universitätsklinikum Freiburg
Für die Anregung zur Beschäftigung mit der Thematik gilt mein Dank Herrn Dr. med. Schneble, Ärztl. Direktor des Epilepsiezentrums Kork
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
09. März 2004 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Zusammenfassung

Operative Eingriffe aller Art sind bei Patienten mit Epilepsien mit speziellen Risiken verbunden. Interaktionen zwischen antikonvulsiver und anästhesiologischer Medikation, prokonvulsive Effekte vieler gebräuchlicher Anästhetika und Gerinnungsstörungen unter Valproattherapie stellen die häufigsten Ursachen von Komplikationen dar. Zusätzliche Problemstellungen ergeben sich aufgrund der Senkung der Anfallsschwelle durch neurochirurgische Eingriffe. In einer Übersicht werden häufige Fragestellungen zur perioperativen Steuerung der Medikation bei Epilepsiepatienten und pragmatische Konzepte zur Risikominderung dargestellt.

Abstract

Surgical interventions are associated with particular risks in patients with epilepsy. Possible interactions between the anticonvulsive treatment and anaesthetic drugs, proconvulsive effects of commonly used anaesthetic drugs, and disturbances of hemostasis due to valproate may cause complications. Additional problems may arise due to the lowered seizure threshold following neurosurgical interventions. An overview on common problems and pragmatic concepts for the handling of epilepsy patients are provided.

Literatur

  • 1 Matthew E, Sherwin A L, Welner S A. et al . Seizures following intracranial surgery: incidence in the first post-operative week.  Canad J Neurol Sci. 1980;  7 285-290
    PubMedGoogle Scholar
  • 2 Kvam D A, Loftus C M, Copeland B, Quest D O. Seizures during the immediate postoperative period.  Neurosurgery. 1983;  12 14-17
    PubMedGoogle Scholar
  • 3 Beemer G H, Dawson P J, Bjorksten A R, Edwards N E. Early postoperative seizures in neurosurgical patients administered atracurium and isofluran.  Anesth Intensive Care. 1989;  17 504-509
    PubMedGoogle Scholar
  • 4 Lamoureux D, Spencer S, Spencer D. Perioperative seizures after epilepsy surgery.  Neurology Neurology. 1994;  44 (S2) A161
    PubMedGoogle Scholar
  • 5 Ornstein E, Matteo R S, Schwartz A E. et al . J The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium.  Anesthesiology. 1987;  67 191-196
    PubMedGoogle Scholar
  • 6 Overweg J, Binnie C D. Benzodiazepines in neurological disorders. 1983: 339-347
    Google Scholar
  • 7 Ornstein E, Matteo R S, Young W L, Diaz J. Resistance to metocurine-induced neuromuscular blockade in patients receiving phenytoin.  Anesthesiology. 1985;  63 294-298
    PubMedGoogle Scholar
  • 8 Ornstein E, Matteo R S, Weinstein J A. et al . Accelerated recovery from doxacurium-induced neuromuscular blockade in patients receiving chronic anticonvulsant therapy.  J Clin Anesth. 1991;  3 108-111
    CrossrefPubMedGoogle Scholar
  • 9 Roth S. Ebrahim ZY. Resistance to pancuronium in patients receiving carbamazepine.  Anesthesiology. 1987;  66 691-693
    PubMedGoogle Scholar
  • 10 Tempelhoff R, Modica P A, Bernardo K L, Edwards P A. Fentanyl-induced electrocortical seizures in patients with compex partial epilepsy.  J Neurosurg. 1992;  77 201-208
    CrossrefPubMedGoogle Scholar
  • 11 Hans P, Ledoux D, Bonhomme V, Brichant J F. Effect of anticonvulsant level on pipecuronium-induced neuromuscular blockade: preliminary results.  J Neurosurg Anesthesiol. 1995;  7 254-258
    PubMedGoogle Scholar
  • 12 Spacek A, Neiger F X, Krenn C G. et al . Rocuronium-induced neuromuscular block is affected by chronic carbamazepine therapy.  Anesthesiology. 1999;  90 109-112
    PubMedGoogle Scholar
  • 13 Jenner M A, Plummer J L, Cousins M J. Halothane reductive metabolism in an adult surgical population.  Anaesth Intens Care. 1990;  18 395-599
    PubMedGoogle Scholar
  • 14 Chalk J B, Ridgeway K, Brophy T. et al . Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients.  J Neurol Neurosurg Psychiatr. 1984;  47 1087-1090
    PubMedGoogle Scholar
  • 15 Jubiz W, Meikle A W, Lewinson R A. et al . Effect of diphenylhydantoin on the metabolism of dexamethasone.  N Engl J Med. 1970;  283 11-14
    PubMedGoogle Scholar
  • 16 McLelland J, Jack W. Phenytoin dexamethasone interaction: a clinical problem.  Lancet. 1978;  1 1096-1097
    PubMedGoogle Scholar
  • 17 Tempelhoff R, Modica P A, Spithnagel E L. Anticonvulsant therapy increases fentanyl requirements during anaesthesia for craniotomy.  Can J Anaesth. 1990;  37 327-332
    PubMedGoogle Scholar
  • 18 Schubert A. Anesthesia für epilepsy surgery. In: Lüders HO, Comair Y (eds) Epilepsy Surgery (2nd ed.). Philadelphia; Lippincott Williams 2001: 623-631
    Google Scholar
  • 19 North J, Hanieh A, Penhall R K, Frewin B D. Double-blind trial of phenytoin in postoperative epilepsy.  Neurosurgery. 1980;  7 293
    PubMedGoogle Scholar
  • 20 Spencer S S, Packey D J. Antiepileptic drug management before and after epilepsy surgery. In: Levy RH, Mattson RH, Meldrum BS (eds) Antiepileptic Drugs (4th ed.). New York; Raven Press 1995: 189-200
    Google Scholar
  • 21 Darling J R, Sharpe P C, Stiby E K. et al . Serum mitochondrial aspartate transaminase activity after isoflurane or halothane anaesthesia.  Br J Anaesth. 2000;  85 195-198
    CrossrefPubMedGoogle Scholar
  • 22 Feil B, Fauser S, Linder M. et al . Perioperative Schwankungen der Serumkonzentrationen von Lamotrigin und Oxcarbazepin.  Z Epileptol. 2003;  16 126
    PubMedGoogle Scholar
  • 23 Bouma P A, Peters A C, Arts R J. et al . Discontinuation of antiepileptic therapy: a prospective study in children.  J Neurol Neurosurg Psychiatry. 1987;  50 1579-1583
    PubMedGoogle Scholar
  • 24 DeToledo J C, Ramsay R E, Lowe M R. et al . Increased seizures after discontinuing carbamazepine: results from the gabapentin monotherapy trial.  Ther Drug Monit. 2000;  22 753-756
    CrossrefPubMedGoogle Scholar
  • 25 Wright P S, Seifert C F, Hampton E M. Toxic carbamazepine concentrations following cardiotharacic surgery and myocardial infarction.  DICP Ann Pharmacother. 1990;  24 822-826
    PubMedGoogle Scholar
  • 26 Dalton M J, Powell J R, Messenheimer J A, Clark J. Cimetidine and carbamazepine: a complex drug interaction.  Epilepsia. 1986;  27 553-558
    PubMedGoogle Scholar
  • 27 Carranco E, Kareus J, Co S. et al . Carbamazepine toxicity induced by concurrent erythromycin therapy.  Arch Neurol. 1985;  42 187-188
    PubMedGoogle Scholar
  • 28 Wons Y Y, Ludden T N, Bell R D. Effect of erythromycin on carbamazepine kinetics.  Clin Pharmacol Ther. 1983;  33 460-464
    PubMedGoogle Scholar
  • 29 Dam H, Kristensen C B, Hansen B S, Christiansen J. Interactions between carbamazepine and propoxyphen in man.  Acta Neurol Scand. 1977;  56 603-607
    PubMedGoogle Scholar
  • 30 Kraemer D L, Spencer D D. Anesthesia in epilepsy surgery. In: Engel J jr (ed) Surgical Treatment of the Epilepsies. New York; Raven Press 1993: 527-538
    Google Scholar
  • 31 Kofke W A, Tempelhoff R, Daseeiff R M. Anesthetic implications of epilepsy, status epilepticus, and epilepsy surgery.  J Neurosurg Anesthesiol. 1997;  9 349-372
    PubMedGoogle Scholar
  • 32 Ito B M, Sato S, Kufta C V, Tran D. Effect of isoflurane and enflurane on the electrocorticogram of epileptic patients.  Neurology. 1988;  38 924-928
    PubMedGoogle Scholar
  • 33 Fritz T, Lenz G, Schorer R. Überlegungen zum Narkoseverfahren bei mitochondrialer Encephalomyopathie.  Anästh Intensivther Notfallmed. 1988;  23 265-270
    PubMedGoogle Scholar
  • 34 Niejadlik K, Galindo A. Electrocorticographic seizure activity during enflurane anesthesia.  Anesth Analg. 1975;  54 722-724
    PubMedGoogle Scholar
  • 35 Burchiel K J, Stockard J J, Calverly R K, Smith N T. Relationship of pre- and postanesthetic EEG abnormalities to enflurane-induced seizure activity.  Anesth Analg. 1977;  56 509-514
    PubMedGoogle Scholar
  • 36 Allan N S. Convulsions after enflurane Anesthesia.  Anesthesia. 1984;  39 605-606
    PubMedGoogle Scholar
  • 37 Fariello R O. Epileptogenic properties of enflurane and their clinical interpretation.  Electroencephalogr Clin Neurophysiol. 1980;  48 595-598
    PubMedGoogle Scholar
  • 38 Grant J S. Delayed convulsions following enflurane anaesthesia.  Anaesthesia. 1986;  41 1024-1025
    PubMedGoogle Scholar
  • 39 Nicoll J MV. Status epilepticus following enflurane anaesthesia.  Anaesthesia. 1986;  41 927-930
    PubMedGoogle Scholar
  • 40 Clark D L, Hosick E C, Adam N. et al . Neural effects of isoflurane in man.  Anesthesiology. 1973;  39 261-270
    PubMedGoogle Scholar
  • 41 Fiol M E, Boening J A, Cruz-Rodriguez R, Maxwell R. Effect of isoflurane (forane) on intraoperative electrocorticogram.  Epilepsia. 1993;  34 897-900
    PubMedGoogle Scholar
  • 42 Grant I S, Hutchison G. Epileptiform seizures during prolonged etomidate sedation.  Lancet. 1983;  511-512
    PubMedGoogle Scholar
  • 43 Ebrahim Z Y, DeBoer G E, Lüders H. et al . Effect of etomidate on the electroencephalogram of patients with epilepsy.  Anesth Anal. 1986;  65 1004-1006
    PubMedGoogle Scholar
  • 44 Opitz A, Marschall M, Degan R, Koch D. General anesthesia in patients with epilepsy and status epilepticus. In: Delgado-Escueta AV, Wasterlain CG, Treiman DM, Porter RJ (eds) Status Epilepticus: Mechanisms of Brain Damage and Treatment. New York; Raven Press 1983: 43-47
    Google Scholar
  • 45 Celesia G C, Chen R C, Bamforth B J. Effects of ketamine in epilepsy.  Neurology. 1975;  25 169-172
    PubMedGoogle Scholar
  • 46 Winters W D. Epilepsy of anesthesia with ketamine.  Anesthesiology. 1972;  36 309-312
    PubMedGoogle Scholar
  • 47 Keene D L, Roberts D, Splinter W M. et al . Alfentanil mediated activation of epileptiform activity in the electrocorticogram during resection of epileptogenic foci.  Can J Neurol Sci. 1997;  24 37-39
    PubMedGoogle Scholar
  • 48 Archer D P, McKenna J M, Morin L, Ravussin P. Conscious-sedation analgesia during craniotomy for intractable epilepsy.  Can J Anaesth. 1982;  35 338-344
    PubMedGoogle Scholar
  • 49 Manninen P, Contreras J. Anesthetic considerations for craniotomy in awake patients.  Int Anesthesiol Clin. 1986;  24 157-174
    PubMedGoogle Scholar
  • 50 Ross J, Kearse L A, Barlow M K. et al . Alfentanil-induced epileptoform activity: a simultaneous surface and depth electroencephalographic study in complex partial epilepsy.  Epilepsia. 2001;  42 220-225
    CrossrefPubMedGoogle Scholar
  • 51 Watts A D, Herrick I A, McLachlan R S. et al . The effect of sevoflurane and isoflurane anesthesia on interictal spike activity among patients with refractory epilepsy.  Anesth Analg. 1999;  89 1275-1281
    PubMedGoogle Scholar
  • 52 Pearce J, Ron M A. Thrombocytopenia after carbamazepine.  Lancet. 1968;  2 223
    PubMedGoogle Scholar
  • 53 Veall R M, Hogarth H C. Thrombocytopenia during treatment with clonazepam.  Br Med J. 1975;  22 462
    PubMedGoogle Scholar
  • 54 Mackay F J, Wilton L V, Pearce G L. et al . Safety of long-term lamotrigine in epilepsy.  Epilepsia. 1997;  38 881-886
    PubMedGoogle Scholar
  • 55 Holtzer C D, Reisner-Keller L A. Phenytoin-induced thrombocytopenia.  Ann Pharmacother. 1997;  31 435-437
    PubMedGoogle Scholar
  • 56 Chalmers J NM, Boheimer K. Megaloblastic anemia and anticonvulsant therapy.  Lancet. 1954;  2 920-921
    PubMedGoogle Scholar
  • 57 Willert C, Englisch S, Schlesinger S, Runge U. Possible drug-induced thrombocytopenia secondary to tiagabine.  Neurology. 1999;  10 888
    PubMedGoogle Scholar
  • 58 Kreuz W, Linde R, Funk M. et al . Valproate therapy induces von Willebrand disease type I.  Epilepsia. 1992;  33 178-184
    PubMedGoogle Scholar
  • 59 Barr R D, Copeland S A, Stockwell M L. et al . Valproic acid and immune thrombocyopenia.  Arch Dis Childhood. 1982;  57 681-684
    CrossrefPubMedGoogle Scholar
  • 60 Sandler R M, Enberson C, Roberts G E. et al . IgM platelet autoantibody due to sodium valproate.  BMJ. 1978;  2 1683-1684
    CrossrefPubMedGoogle Scholar
  • 61 Delgado M R, Riela A R, Mills J. et al . Thrombocytopenia secondary to high valproate levels in children with epilepsy.  J Child Neurol. 1994;  9 311-314
    PubMedGoogle Scholar
  • 62 Gidal B, Speencer N, Maly M. et al . Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.  Neurology. 1994;  44 1418-1422
    PubMedGoogle Scholar
  • 63 Davis R G, Sunder T, Barakat H A, May R. Valproate alters the membrane phospholipids of erythrocytes.  Epilepsia. 1991;  32, Suppl 3 11-12
    PubMedGoogle Scholar
  • 64 Neophytids A N, Nutt J G, Lodish J R. Thrombocytopenia associated with sodium valproate treatment.  Ann Neurol. 1979;  5 389-390
    CrossrefPubMedGoogle Scholar
  • 65 Sutor A, Jesdinsky-Buscher C. Veränderungen der Hämostase bei Epilepsie-Behandlung mit Dipropylessigsäure.  Fortschr Med. 1976;  94 411-414
    PubMedGoogle Scholar
  • 66 Kreuz W, Linde R, Funk M. et al . Induction of von Willebrand disease type I by valproic acid.  Lancet. 1990;  335 1350-1351
    PubMedGoogle Scholar
  • 67 Ruggeri Z M, Zimmermann T S. von Willebrand factor and von Willebrand disease.  Blood. 1987;  70 895-904
    PubMedGoogle Scholar
  • 68 Werner E J, Abshire T C, Giroux D S. et al . Relative value of diagnostic studies for von Willebrand disease.  J Pediatr. 1992;  121 34-38
    PubMedGoogle Scholar
  • 69 Day H J, Rao A K. Evaluation of platelet function.  Semin Hematol. 1986;  23 89-101
    PubMedGoogle Scholar
  • 70 Tanindi S, Akin R, Köseoglu V. et al . The platelet aggregation in children with epilepsy receiving valproic acid.  Thrombosis Res. 1996;  81 471-476
    CrossrefPubMedGoogle Scholar
  • 71 Gil-Fernandez J J, Gómez N, Pinilla I. Valproic acid produces von Willebrand syndome and prolongs bleeding time in epileptic adults: study of 55 patients from one center.  Thromb Haemost. 1997;  Suppl 216a
    PubMedGoogle Scholar
  • 72 Verrotti A, Greco R, Matera V. et al . F Platelet count and function in children receiving sodium valproate.  Pediatr Neurol. 1999;  21 611-614
    CrossrefPubMedGoogle Scholar
  • 73 Shepherd L L, Hutchinson R J, Worden E K. et al . Hyponatremia and seizures after intravenous administration of desmopressin acetate for surgical hemostasis.  J Pediatr. 1989;  114 470-472
    PubMedGoogle Scholar
  • 74 Dale B M, Purdle G H, Rischbieth R H. Fibrinogen depletion with sodium valproate.  Lancet. 1978;  1 1316-1317
    PubMedGoogle Scholar
  • 75 Hauser E, Seidl R, Freilinger M. et al . Hematologic manifestations and impaired liver synthetic function during valproate monotherapy.  Brain Dev. 1996;  18 105-109
    CrossrefPubMedGoogle Scholar
  • 76 Teich M, Longin E, Dempfle C E, König S. A Factor XIII deficiency under therapy with valproate.  Neuropediatrics. 2001;  33 A36
    PubMedGoogle Scholar
  • 77 Zhu Y, Tassi L, Lane W, Mendelsohn M E. Specific binding of the transglutaminase, platelet factor XIII.  J Biol Chem. 1994;  269 22379-22384
    PubMedGoogle Scholar
  • 78 Gerlach R, Raabe A, Zimmermann M. et al . Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures.  Surg Neurol. 2000;  54 260-264
    CrossrefPubMedGoogle Scholar
  • 79 Pohlmann-Eden B, Peters C N, Wennberg R, Dempfle C E. Valproate induces reversible factor XIII deficiency with risk of perioperative bleeding.  Acta Neurol Scand. 2003;  108 142-145
    CrossrefPubMedGoogle Scholar
  • 80 Ranganathan C, Verma N P, Diaz F G. Valproate and epilepsy surgery.  J Epilepsy. 1993;  6 142-144
    CrossrefPubMedGoogle Scholar
  • 81 Riol Diego M, Narbona García J. Tratamiento con valproato y complicación cerebral.  An Esp Pediatr. 1997;  46 621-624
    PubMedGoogle Scholar
  • 82 Tetzlaff J. Intraoperative defect in hemostasis in a child receiving valproic acid.  Can J Anaesth. 1991;  38 222-224
    PubMedGoogle Scholar
  • 83 Anderson G D, Lin Y-Y, Berge C, Ojeman G A. Absence of bleeding complication in patients undergoing cortical surgery while receiving valproate treatment.  J Neurosurg. 1997;  87 252-256
    CrossrefPubMedGoogle Scholar
  • 84 Ward M M, Barbaro N M, Laxer K D, Rampil I J. Preoperative valproate administration does not increase blood loss during temporal lobectomy.  Epilepsia. 1996;  37 98-101
    PubMedGoogle Scholar
  • 85 Winter S L, Kriel R L, Novacheck T F. et al . Perioperative blood loss: the effect of valproate.  Pediatr Neurol. 1996;  15 19-22
    CrossrefPubMedGoogle Scholar
  • 86 Sato K, Shamoto H, Yoshimoto T. Severe bradycardia during epilepsy surgery.  J Neurosurg Anesthesiol. 2001;  13 329-332
    CrossrefPubMedGoogle Scholar
  • 87 Thompson V A, Wahr J A. Anesthetic considerations in patients presenting with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome.  Anesth Analg. 1997;  85 1404-1406
    PubMedGoogle Scholar
  • 88 Modica P A, Tempelhoff R, White P F. Pro- and anticonsulvant effects of anesthetics (part II).  Anesth Analg. 1990;  70 433-444
    CrossrefPubMedGoogle Scholar
  • 89 Herrick I A, Craen R A, Gelb A W. et al . Propofol sedation during awake craniotomy for seizures: patient-controlled administration versus neurolept analgesia.  Anesth Analg. 1997;  84 1285-1291
    PubMedGoogle Scholar
  • 90 Faulconer A, Pender J W, Bickford R G. The influence of partial pressure of nitrous oxide on the depth of anesthesia and the electroencephalogram in man.  Anesthesiology. 1949;  10 601-609
    PubMedGoogle Scholar
  • 91 Ruggeri Z M, Mannucci P M, Lombardi R. et al . Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP. Implications for pathophysiology and therapy of von Willebrand's disease subtypes.  Blood. 1982;  59 1272-1278
    PubMedGoogle Scholar
  • 92 Mannucci P M, Vicente V, Alberca I. et al . A Intravenous and subcutaneous administration of desmopressin (DDAVP) to hemophilics: pharmakokinetics and factor VIII responses.  Thromb Haemost. 1987;  58 1037-1039
    PubMedGoogle Scholar
  • 93 Lethagen S, Harris A S, Nilsson I M. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.  Blut. 1990;  60 187-191
    PubMedGoogle Scholar

Dr. med. Andreas Schulze-Bonhage

Sektion Prächirurgische Epilepsiediagnostik · Neurozentrum der Universität Freiburg

Breisacher Straße 64

79106 Freiburg

eMail: schulzeb@nz.ukl.uni-freiburg.de

      >